End-of-day quote
Korea S.E.
06:00:00 2024-05-02 pm EDT
|
5-day change
|
1st Jan Change
|
1,711
KRW
|
-0.23%
|
|
+1.60%
|
-21.33%
|
2023 |
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
|
CI
| 2023 |
NEXTURNBIOSCIENCE Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
|
CI
|
|
2024-04-26
|
2024-04-29
|
2024-04-30
|
2024-05-02
|
2024-05-03
|
Last |
1684 ₩
|
1689 ₩
|
1718 ₩
|
1715 ₩
|
1711 ₩
|
Volume |
153 667 |
106 839 |
235 370 |
144 688 |
107 227 |
Change |
+0.30%
|
+0.30%
|
+1.72%
|
-0.17%
|
-0.23%
|
Opening |
1,679.00 |
1,684.00 |
1,697.00 |
1,712.00 |
1,715.00 |
High |
1,691.00 |
1,697.00 |
1,722.00 |
1,730.00 |
1,721.00 |
Low |
1,668.00 |
1,684.00 |
1,683.00 |
1,700.00 |
1,701.00 |
Avg. Volume 20 sessions
200 932
Avg. Volume 20 sessions KRW
343 794 652.00
Avg. Volume 20 sessions USD
252 345.27
Record volume 1
84 880 220
Record volume 2
74 058 590
Record volume 3
57 523 550
Capital turnover ratio
0.00
Capitalization (KRW)
161 951 317 439
Capitalization (USD)
118 872 267
Net sales (KRW)
46 483 649 020
Net sales (USD)
34 118 998
Sales / Employee (KRW)
193 681 871
Sales / Employee (USD)
142 162
Free-Float capitalization (KRW)
144 980 490 191
Free-Float capitalization (USD)
106 415 680
Average Daily Capital Traded
0.21%
Moving average 5 days
1 703.40
Moving average 20 days
1 680.70
Moving average 50 days
1 811.36
Moving average 100 days
2 001.18
Price spread / (MMA5) -0.44% Price spread / (MMA20) -1.77% Price spread / (MMA50) +5.87% Price spread / (MMA100) +16.96%
More charts
|